Q Investor Kit January December 2015

Similar documents
Q Investor Kit JANUARY-MARCH 2014

Q Investor Kit JANUARY-JUNE 2014

Q Investor Kit January December 2014

Q Investor Kit JANUARY-JUNE 2013

Q Investor Kit JANUARY-MARCH 2013

SWEDISH MATCH INVESTOR KIT Q4 2016

Q2 INVESTOR KIT JANUARY-JUNE 2011

SWEDISH MATCH RESULTS PRESENTATION Q3 2017

SWEDISH MATCH RESULTS PRESENTATION Q4 2018

Lars Dahlgren. President and CEO

COMPANY PRESENTATION 2017

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

Telekom Austria Group Results for the 1st Quarter May 27, 2003

THIRD QUARTER REPORT 2011 (UNAUDITED)

Global Smokeless Tobacco Market

RAI: Strong key-brands performance delivers 2Q13 profit growth; Company reaffirms full-year EPS guidance

Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 25, András Tövisi Chairman of the Board of Directors

Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 27, 2018

Hyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011

For personal use only

WntResearch. 100% one-week return? 16 October 2017 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE

Coloplast A/S. Investor presentation 1H 2005/06

For personal use only

Third-quarter results 2013

Altria Group Inc. Ticker: MO

VITROLIFE AB (PUBL) NORDEA Small & Mid Cap Seminar

RAI reports strong 2Q16 performance and positive outlook; Accelerates returns to shareholders

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018

Summary of Results for the First Half of FY2015/3

Endesa 1Q 2017 Results 09/05/2017

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS

VITROLIFE AB (PUBL) Pareto Securities Health Care Conference

METVIX PDT ON THE MARKET IN GERMANY AND UK

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM

Interim Report 1 January September 2017

BALCHEM CORPORATION. Q Investor Relations Presentation

Presentation First quarter 2006

CENTRALE. Monetary. compared. domestic. million.

RAI increases 3Q13 earnings on strong operating performance; tightens full-year EPS guidance

Enel Américas 1Q 2018 results

Value creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO

FIRSTQUARTER2018 RESULTSPRESENTATION

PhotoCure ASA Presentation First quarter 2005 May 3, 2005

OUTLOOK FOR U.S. TOBACCO. Tom Capehart Agricultural Economist Economic Research Service U.S. Department of Agriculture

Slide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A

Altria Group Inc (MO-NYSE)

ADM to Acquire Neovia and Probiotics International Limited. July 2, 2018

Interim report Second quarter 2017 and subsequent events (Unaudited)

ELICA 2012 Q3 RESULTS. November 14,

Company overview. Highlights for the 1 st quarter 2018 (January-March)

JT Group Consolidated Financial Results 2018 First Quarter Results

Forward Looking Information

DELICA D:5 ACTIVE GEAR 0

Imperial Brands Maximising Category Opportunities CAGNY February 2019

ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update

Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs

FY2009 First Quarter Financial Results. SUZUKI MOTOR CORPORATION August 3, 2009

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

Reynolds American to Acquire Lorillard

Growth in core businesses offsets weaker non-interest income. DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts

Increase in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) H revenues and results - 24 July 2014

KAPITALMARKNADSDAG 20 SEPTEMBER Thomas Axelsson, CEO

FY2007 Consolidated Financial Overview

A world leader in allergy immunotherapy

Designing a Smoke-Free Future

Results Briefing. 15 ~ 17 May 2007

Presentation of. Burgdorf, 1 st November 2012

WntResearch. Pearls on a string. 3 September 2018 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE

Slide 1. Investor presentation. London 5 February 2019

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015

Straumann reports 4% growth in local currencies (l.c.) in the first nine months of 2010

Consolidated: Financial Summary

2014 CAGNY Investor Presentation. February 19, 2014

Welcome to LG Electronics

PhotoCure ASA. Presentation. Results 1 Quarter 2004

Walgreens (WAG) Analyst: Juan Fabres Fall 2014

Report for the fourth quarter of 2016 and subsequent events (Un-audited)

BANK HANDLOWY W WARSZAWIE S.A. 1Q 2009 consolidated financial results -1-

(LO-NYSE) SUMMARY. Risk Level *

ASL MARINE. DBS Vickers Pulse of Asia Roadshow 10 January 2012

Investor Day Lausanne, September 27, 2018

Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO

Zacks Small-Cap Research

TELECONFERENCE Q August 2015

Leading Intimate Healthcare

1Q2017 法人說明會 Jun. 9, 2017

Small-Cap Research. Diffusion Pharmaceuticals Inc. (DFFN-NASDAQ) DFFN: FDA Gives Final Guidance for Phase 3 Protocol for TSC in Inoperable GBM OUTLOOK

INVESTOR PRESENTATION

YEAR END REPORT. September 2013 August Diamyd Medical AB (publ), Fiscal year 2013/2014

A GLOBAL LEADER IN PERSONALIZED NUTRITION

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical

Self-regulation program for the sale of tobacco products

QUARTERLY REPORT 2. September 2017 February Diamyd Medical AB (publ), Fiscal year 2017/2018

Financial results in line with expectations and important progress of the pipeline

Leading Intimate Healthcare. Investor presentation Q1 2007/08

NASDAQ: FHCO 2016 Annual Meeting

Vontobel Viewpoints FDA New Direction on Tobacco Our Take

Valneva Reports Strong Q1 Revenue Growth and Positive EBITDA Reaffirms Financial Guidance and Pipeline Outlook for 2017

Very good Q3 contribution from Vegetable Juices Inc.

REATA PHARMACEUTICALS, INC. ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS AND AN UPDATE ON DEVELOPMENT PROGRAMS

Transcription:

Q4 2015 Investor Kit January December 2015

Summary and Overview 2

Q4 and full year 2015: Headline numbers Sales for the full year increased by 9 percent and for the fourth quarter by 5 percent. In local currencies, sales increased by 2 percent for both the full year and the fourth quarter. Operating profit from product areas* for the full year increased by 7 percent and for the fourth quarter by 1 percent. In local currencies, operating profit from product areas* declined by 2 percent for the full year and declined by 4 percent for the fourth quarter. Swedish Match has, beginning this reporting period, started reporting its share of STG s net profit with a one quarter lag, due to differences in reporting schedules between Swedish Match and STG. Due to this, no net profit from STG was recognized for the October-December 2015 period. Operating profit** (excluding share of STG s net profit for the fourth quarter 2015 due to changed reporting) amounted to 4,008 MSEK (3,780) for the full year and to 908 MSEK (992) for the fourth quarter. EPS (basic) for the full year amounted to 14.48 SEK (13.23) and to 3.34 SEK (3.55) for the fourth quarter. The decline in EPS for the fourth quarter was fully attributable to the changed reporting relating to STG. The Board of Directors proposes a dividend of 20.00 SEK per share consisting of an increased ordinary dividend of 8.00 SEK (7.50) and a special dividend of 12.00 SEK, following Swedish Match s partial divestment of STG in conjunction with the listing of STG on Nasdaq Copenhagen. * Operating profit for Swedish Match product areas, which excludes share of net profit in STG. ** Operating profit for the Group includes larger one-time items and share of net profit in STG. 3

Q4: Developments in the Scandinavian snus business Good market growth and largely stable market share in Sweden Scandinavian snus market grew by approximately 5% Estimated underlying YTD market growth of close to 5%. Norwegian market growing faster than the Swedish market. Swedish Match s volumes estimated to be up by 4% adjusting for hoarding effects in Q4 and up by more than 2% for the full year adjusting for hoarding/calendar effects. Swedish market share in volume terms was 69.3 percent for the quarter Down 0.3 percentage points versus prior year Q4. Market share gains in the growing value segment* for snus in Sweden Swedish Match s market share in the value segment* increased to slightly more than 41%. Continued market share declines in Norway but good performance from more recently added products Share gains for General G.3 pouch products could not compensate for challenging trends for some of the Company s other products and overall market shares continued to decline. A weaker Norwegian krone (NOK) and price/mix effects in Sweden reduced average selling price per can Successful launch of XRANGE and higher share of value priced products in the portfolio. * Swedish Match estimates based on Nielsen data. 4

Q4: Scandinavian product launches continued to drive volume XRANGE in Sweden Continued share growth for XRANGE, with more than 5% of the market. Contributed to growth of key brands and a more stable premium segment. Göteborgs Rapé including XRANGE variety now one of the faster growing brands on the market. Part of longer term strategy to strengthen Swedish Match s share across all price segments. Other launches, Sweden Mustang, priced at the upper end of the value segment introduced in three varieties in September. Göteborgs Rapé pouches introduced in original format in September. Norway General G.3 range continued to gain share in the fourth quarter. New products in The Lab and Nick & Johnny series launched. 5

Q4: Continued strong performance in the US Growth driven by solid underlying performance in US, and stronger USD Strong results for Other tobacco products (OTP) from cigars OTP sales up 15% in local currency. OTP operating profit up 11% in local currency. Year on year operating profit benefited from lack of tobacco quota buy-out fees. Still no cigar FDA fees. Cigar sales up on volume growth and an improved mix. Cigar volumes increased by 20% to a record high level, exceeding 300 million sticks for the fourth consecutive quarter, and delivered higher operating profit in USD. Chewing tobacco volumes and operating profit in local currency declined. US snus and moist snuff revenues grew Sales increased in USD, while operating profit declined on somewhat higher costs. US snus volumes continued to grow faster than overall market. Total moist snuff volumes down, while tubs delivered higher volumes, pouch volumes increased when adjusted for prior year shipments for new distribution. 6

Regulatory developments Regulatory developments for snus and excise taxes in Scandinavia In Sweden, snus excise taxes were virtually unchanged as of January 1. In Norway, snus excise taxes increased by 2% as of January 1. In Sweden the Ministry of Health and Social Affairs has submitted its proposal for transposition of the European tobacco directive (TPD) into Swedish Law to the Committee on Health and Welfare. The Public Health Agency is proposed to have extended authority with regard to provisions regarding snus, e.g. warning labels, reporting requirements and user fees. Warning label for snus mandatory on two sides of the can. Snus is exempted from the prohibition to communicate flavors on the packaging. In Sweden a Committee of Enquiry is evaluating further tobacco control measures and the report is due March 1. In Norway the proposal on transposition of the TPD as well as potential further tobacco control measures has not yet been published. Proposal has been delayed and is expected to be published before the summer. FDA oversight of cigars likely to begin in 2016 The Food and Drug Administration has submitted its final ruling of the Family Smoking Prevention and Tobacco Control Act for review. When implemented, FDA fees (based on volumes) will be incurred (estimated to be approximately 2 MUSD per quarter). Modified Risk Tobacco Product (MRTP) application process in the US Swedish Match has not yet heard back from FDA, and is confident that applications provide all necessary support for the Company s modified risk status for General snus. 7

Scandinavian Tobacco Group (STG) Swedish Match has started reporting its share of STG s net profit with a one quarter lag, due to differences in reporting schedules between Swedish Match and STG Due to the changed reporting, no net profit from STG was recognized for the October- December 2015 period. IPO intent announced on January 14, 2016 Offering circular published on January 28, 2016 On February 10, 2016, STG began trading on Nasdaq Copenhagen Offer price of 100 DKK. 17.8 million shares sold by Swedish Match. At completion of the IPO, Swedish Match ownership was reduced to 31.2 million shares. Intention to distribute proceeds to shareholders through a special dividend. Board of Directors to propose special dividend of 12.00 SEK per share in addition to ordinary dividend at the company AGM. Capital gain in excess of 500 MSEK not subject to taxation will be recognized in the financial statement for the first quarter of 2016. 8

Detail information and Financials 9

Sales performance for Q4 and full year Increased sales Fourth quarter sales increased by 5% to 3,719 MSEK (3,536), up by 2% in local currencies. Full year sales increased by 9% to 14,486 MSEK (13,305), up by 2% in local currencies. Snus and moist snuff product area: Q4 sales virtually unchanged in SEK Fourth quarter sales down 2% in local currencies. Scandinavian sales flat when adjusting for hoarding effects and the currency effects from the weaker Norwegian krone. US sales up for snus, moist snuff sales grew in local currency slightly as pricing offset lower volumes. Full year sales down 2% in local currencies. Sales in Scandinavia declined due to currency, hoarding, and portfolio price/mix effects. Sales for US snus grew strongly and Moist snuff sales increased due to somewhat higher average price per can and volumes in line with prior year. Other tobacco products product area: sales significantly up Fourth quarter sales up by 32%, and up by 15% in local currency. Full year sales up by 35%, and up by 10% in local currency. Lights product area: sales down on lower volumes/negative currency effects Fourth quarter sales down on lower volumes and a substantially weaker Brazilian real. Full year sales were flat. 10

Operating profit from product areas for Q4 and full year (1/2) Operating profit from product areas up in SEK, down in local currencies Fourth quarter operating profit from product areas up 1%, down 4% in local currencies. Full year operating profit from product areas up 7%, down 2% in local currencies. Snus and moist snuff: operating profit down in the fourth quarter and for the full year Fourth quarter operating profit down 5%. Lower operating profit and somewhat lower margin in Scandinavia, negatively affected by hoarding effects, a weaker NOK and price/mix effects. US snus and moist snuff operating profits down in US dollars, negatively impacted by higher costs. Full year operating profit down 6%. Scandinavian operating profit down on weaker NOK, price/mix, and hoarding effects. US snus and moist snuff operating profits up in US dollars. Operating loss relating to international snus investments: Lower in local currency for both the fourth quarter and for the full year. 11

Operating profit from product areas for Q4 and full year (2/2) Other tobacco products: operating profit up driven by higher cigar volumes Fourth quarter operating profit up 27%, up 11% in local currency. Higher profits from cigars, profits down for chewing tobacco. Positively affected by the absence of the tobacco quota buy-out fees. Full year operating profit up 40%, up 14% in local currency. Strong profit growth for cigars, profits down for chewing tobacco. Positively affected by the absence of the tobacco quota buy-out fees. Lights: operating profit down, impacted by currencies and weak performance in Brazil Operating profit down in the fourth quarter and for the full year due to volume declines and higher costs, including higher marketing support for lighters. Currency translation has affected the comparison of the operating profit positively by 45 MSEK for the fourth quarter and by 309 MSEK for the full year 12

Sales and operating profit Sales and operating profit by product area Q4 2015 Full year 2015 Sales, SEK Operating profit*, SEK Sales, SEK Operating profit*, SEK 5% 5% 30% 35% 29% 35% 9% 38% 57% 9% 41% 54% 26% 26% Snus and moist snuff Other tobacco products Lights Other operations Snus and moist snuff Other tobacco products Lights Other operations * Excluding Other operations, share of net profit in STG. Totals may not add up due to rounding. 13

Sales by currency block Percent of sales, MSEK Q4 2015 Full year 2015 11% 11% SEK USD All other* 36% 53% 37% 52% Excluding Other operations SEK 16% 33% 15% 32% USD All other* 51% 53% * Primarily NOK and BRL. 14

Snus and moist snuff Leading position for snus in Scandinavia The third largest producer of moist snuff in the US General is the second largest and fastest growing snus brand in the US Production in Sweden and the US 15

Snus and moist snuff (Q4 commentary) Progress in defending and developing market positions Scandinavia snus volumes up and sales flat adjusted for hoarding and currency effects Shipment volumes flat year on year, but up by 4% adjusted for prior year trade hoarding effects. Strong share progression for XRANGE and successful launch of Mustang. Operating profit lower due to lower hoarding effects, price/mix and currency (NOK). US moist snuff/snus sales up Continued volume growth for moist snuff tubs, pouch volumes also up when adjusted for prior year shipments for new distribution. Snus sales up on higher volumes and better realized pricing, operating loss in US dollars on par with prior year levels. Continued investment behind snus outside Scandinavia Net costs for snus expansion outside Scandinavia were 90 MSEK (100), impacted by the stronger US dollar, unwinding of SMPM International JV. Operating margin lower Higher relative share of US business, a somewhat lower operating margin in Scandinavia from mix and NOK, and certain temporary cost effects. MSEK Q4-2015 Q4-2014 chg Full year 2015 Full year 2014 Sales 1,318 1,323 0 5,090 5,001 2 Operating profit 545 577-5 2,071 2,207-6 Operating margin, % 41.4 43.6 40.7 44.1 chg 16

Scandinavian market growth and share estimates Scandinavian snus market up by more than 5% in volume in Q4* Scandinavian snus market grew by somewhat more than 5%*. Swedish Match s year on year market share decline in Scandinavia continued to mitigate. Swedish Match maintains strong market share in growing value segment* in Sweden, up more than two percentage points compared to the prior year quarter. Norwegian market grew at a faster pace than the Swedish market. Share gains for General G.3, but overall market share continued to decline. Consumption growth for Swedish Match snus during the fourth quarter year on year was stronger than during the first three quarters. Swedish Match s market shares** Percent October-December Chg Full year Chg 2015 2014 ppts 2015 2014 ppts Snus, Sweden, total 69.3 69.7-0.3 69.3 70.5-1.2 Snus, Sweden, premium 93.7 94.2-0.5 94.2 94.9-0.7 Snus, Sweden, value 41.0 38.7 2.3 39.1 36.3 2.8 Snus, Norway, total 55.3 58.7-3.5 56.6 60.1-3.5 * Source: Swedish Match estimates. ** Swedish Match estimates using Nielsen data (excl. tobacconists due to small sample of tobacconists in Nielsen data). 13 weeks and YTD to December 27, 2015. All figures for the Swedish market have been restated to include nicotine free products (i.e. Onico etc.). 17

Snus and moist snuff Swedish Match shipment volumes October-December Chg Full year Chg 2015 2014 % 2015 2014 % Snus, million of cans, Scandinavia 65.0 64.8 0 237.9 238.1 0 Moist snuff, millions of cans, US 28.7 29.7-3 132.1 132.6 0 18

Improving market share development in Scandinavia Change in Swedish Match volume market share year on year; percentage points of total market Sweden and Norway Q4 2013 Q1 2014 Q2 2014 Q3 2014 Q4 2014 Q1 2015 Q2 2015 Q3 2015 Q4 2015-1,1% -0,9% -1,5% -1,7% -1,8% -2,8% -2,7% -2,5% -4,0% Source: Nielsen DVH+SVH excluding tobacconists, ending December 27, 2015. Adjusted for more representative weight on Nielsen coverage in Norway vs. Sweden. 19

Manufacturer share by price segment to December 27, Sweden Total volume shares 1,4% 6,9% Swedish Match Competitor 1 Competitor 2 Competitor 3 Other 15,1% 7,3% 69,3% 27 December 2015 (4 weeks ending), Swedish Match share of: Premium segment: 93.5% Value segment: 40.9% Total market: 69.3% Share of premium segment 4,0% 1,0% 1,3% Share of value segment 1,9% 14,9% 41,0% 28,0% 93,7% 14,3% Source: Swedish Match estimates based on Nielsen (excluding tobacconists), 12 weeks ending December 27, 2015. All figures for the Swedish market have been restated to include nicotine free products (i.e. Onico etc.). 20

Estimated snus consumption, Scandinavia Million cans 400 360 320 280 240 200 160 120 80 40 0 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Source: Swedish Match estimates, adjusted for hoarding in Sweden. 21

Moist snuff market growth and share estimate US moist snuff market volume up by 2-3% for the full year Category growth continues to be driven by pouches. Swedish Match moist snuff market share in the US down slightly Swedish Match estimates its market share based on industry shipments to be 8-9%. Source: Swedish Match and industry estimates. 22

US moist snuff category development Category by segment: loose vs. pouches Million cans 1 500 1 400 1 300 1 200 1 100 1 000 900 800 700 600 500 400 30 782 35 836 42 882 50 943 Loose Pouches 125 114 75 92 61 1 152 1 189 1 072 1 078 1 007 169 190 210 144 1 230 1 261 1 264 1 273 13.0% CAGR 2010-2015 POUCHES 2.0% CAGR 2010-2015 LOOSE 300 200 100-2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Source: Swedish Match and industry estimates. 23

Other tobacco products US cigars Swedish Match is a major player in the US cigar market. Production takes place in Santiago, Dominican Republic and Dothan, Alabama. Chewing tobacco Nearly all chewing tobacco sales are in the US and Swedish Match is the largest producer. Production takes place in Owensboro, Kentucky. 24

Other tobacco products (OTP), with Q4 commentary Cigar volume growth, driven by natural leaf cigars In local currency, OTP sales were up 15% and operating profit was up 11% Sales, operating profit, and volumes up for cigars Operating profit increased on higher volumes, positive mix and the absence of tobacco buy-out quota fee (ended on October 1, 2014). Cigar volumes up 20%, and up 12% year to date. Continued strong volume development of Game by Garcia y Vega and 1882 natural leaf cigars. Volume growth also for the Jackpot brand. Chewing tobacco sales slightly higher, operating profit declined Positive pricing offset volume declines. Volume declined by 4% for own brands in quarter. More modest pace than for the year to date decline of 6%. MSEK Q4-2015 Q4-2014 chg Full year 2015 Full year 2014 Sales 955 723 32 3,829 2,832 35 Operating profit 366 288 27 1,554 1,109 40 Operating margin, % 38.3 39.8 40.6 39.2 chg 25

Other tobacco products Swedish Match s US shipment volumes for cigars and chewing tobacco October-December Chg Full year Chg 2015 2014 % 2015 2014 % Cigars, millions of sticks 319 266 20 1,256 1,125 12 Chewing tobacco, thousands of pounds (excl. contract manufacturing) 1,670 1,732-4 7,390 7,856-6 26

Lights (with Q4 commentary) Operating profit down, impacted by currencies and weak performance in Brazil Swedish Match is market leader in many markets. The brands are mostly local and hold a strong position in their respective markets Main markets EU, Brazil, Asia and East Europe Production in Brazil, the Netherlands, the Philippines and Sweden Lighter volumes down, sales slightly lower Lower volumes in Brazil, Russia, and parts of Asia. Lower operating profit partly due to increased marketing support. Lower volumes and sales reduce operating profit for matches Higher production costs in Brazil on lower volumes. Negative impact in SEK from decline of Brazilian real. MSEK Q4-2015 Q4-2014 chg Full year 2015 Full year 2014 Sales 334 362-8 1,295 1,295 0 Operating profit 50 63-20 190 218-13 Operating margin, % 14.9 17.3 14.7 16.8 chg 27

Tax, cash flow and financing Tax rate for the Group was 20.9% for the full year Includes profit and loss impact from associated companies. The reported tax rate, excluding associated companies and joint ventures, was 23.1%. Affected by the stronger US dollar and earnings growth in the US. Cash flow Cash flow from operating activities for the full year was 3,768 MSEK (3,276). Improved EBITDA and dividends received from Associates. Net cash used in investing activities amounted to 513 MSEK (274) for the full year. Cash distributed to shareholders During the year, Swedish Match repurchased 7.5 million shares for 1,995 MSEK. During the same period the Company sold treasury shares of 141 MSEK as a result of option holders exercising options (all in Q1). 28

Tax, cash flow and financing Financial policy Dividend policy: 40-60% of earnings per share. 2015 proposed ordinary dividend: 8.00 SEK per share (7.50). Proposed special dividend of 12.00 SEK per share following Swedish Match s partial divestment of STG in conjunction with STG s listing on Nasdaq Copenhagen. Net debt not to exceed 3 times EBITA*. Financing The net finance cost for the full year declined to 463 MSEK (510), mainly as a result of lower average interest bearing debt excl. retirement benefit obligations. During the year new bond loans of 798 MSEK were issued. Repayments of bond loans for the same period amounted to 1,435 MSEK. As of December 31, 2015 Swedish Match had 8,064 MSEK of interest bearing debt excluding retirement benefit obligations compared to 8,703 MSEK at December 31, 2014. In February, 2016, 250 MSEK of debt falls due for payment and 400 MSEK in December Cash and cash equivalents amounted to 1,732 MSEK at the end of the period, compared to 2,312 MSEK at December 31, 2014. Net debt/ebita per December 31 was at 2.1* compared to 2.3* previous year. * Excluding share of net profit in STG. Operating profit adjusted for amortization and write-downs of intangible assets. 29

Maturity profile of interest bearing liabilities As of December 31, 2015 MSEK 3 500 3 000 2 500 2 000 1 500 Fixed Float 1 000 500 0 2016 2017 2018 2019 2020 2022 2023 2028 Year 30

Other events and events after the reporting period SMD Logistics AB reached an agreement to sell its distribution facility in Solna, Sweden, and reached an agreement to acquire a new distribution center located in Kungsängen, Sweden The new distribution center went into operation in the beginning of 2016. At the same time, SMD Logistics AB s current distribution center was consolidated into the new distribution center. The sale of the distribution center in Solna is planned to be concluded at the end of the first quarter 2016 for approximately 150 MSEK at which time a capital gain estimated to be in excess of 140 MSEK will be recognized. The plan is to also divest the Hisings Backa distribution facility in the future. The investment in the new distribution center amounts to approximately 150 MSEK and was paid in October 2015. On January 10, 2016 Scandinavia Tobacco Group was listed on Nasdaq Copenhagen The IPO consisted of a partial sale of existing shares by the STG shareholders, Swedish Match and Skandinavisk Holding II A/S. The shareholders offered to sell 35.6 percent in the offering with an overallotment option of another 4.4 percent. The IPO closed on February 9, 2016, and admission to trading and listing of the STG shares on Nasdaq Copenhagen took place on February 10, 2016. Swedish Match reduced its ownership in STG in the IPO from 49.0 percent (49.0 million shares) to 31.2 percent (31.2 million shares) at completion of the offering. Assuming full exercise of the overallotment option at a later date, Swedish Match will hold 29.0 percent of STG (29.0 million shares). 31

2015 full year report outlook statement For 2016, on a full year basis, we expect Scandinavian snus as well as US moist snuff consumption to continue to grow as measured in number of cans. In our Scandinavian snus business, the average net selling price per can is expected to decline slightly versus prior year as modest price increases are offset by the effect of the weakened Norwegian krone, mix effects attributable to the successful launch of XRANGE, and growth of the value segment. Since December 2015 the competitive activity level in the Swedish snus market has increased and we expect it to remain high for the remainder of the year. For our US moist snuff business, we expect higher prices to more than compensate for negative mix effects during the year. We will continue to work hard to defend our market shares in both Scandinavia and in the US. For cigars in the US, Swedish Match expects the market to continue to grow in 2016 but to remain highly competitive. Swedish Match expects the US Food and Drug Administration (FDA) to begin regulating cigars during the year and in conjunction with this Swedish Match, like the rest of the cigar industry, will be subject to user fees to the FDA. Swedish Match will continue to invest in growth outside Scandinavia in 2016 and expects the US snus business to continue to grow and to deliver increased gross profit and reduced operating loss. Swedish Match generates a substantial share of its sales and operating profit in the US. During 2015, the stronger US dollar compared to 2014 had a significant positive effect on both sales and operating profit growth. For 2016, Swedish Match expects a much less pronounced currency translation impact. The effective corporate tax rate, excluding associated companies, is expected to be somewhat higher for 2016 than for 2015. The Company maintains its financial strategy and dividend policy, and we remain committed to returning cash not needed in operations to shareholders. 32

P&L in summary MSEK Q4-2015 Q4-2014 Chg % Full year 2015 Full year 2014 Chg % Sales 3,719 3,536 5 14,486 13,305 9 Cost of goods sold -2,005-1,910-7,697-7,109 Gross profit 1,714 1,627 5 6,789 6,197 10 Selling and administrative expenses -808-170 -3,065-2,703 Share of profit/loss in associated companies and joint ventures* 2 75 327 285 Relocation of distribution facilities - - -42 - Operating profit* 908 992-8 4,008 3,780 6 Finance income 9 5 22 27 Finance costs -137-137 -486-537 Net finance cost -128-132 -463-510 Profit before income tax 780 861-9 3,545 3,270 8 Income tax expense -145-161 -742-644 Profit for the period* 636 700-9 2,803 2,626 7 Earnings per share, basic, SEK 3.34 3.55 14.48 13.23 Earnings per share, adjusted, basic, SEK* 3.34 3.55 14.36 13.23 Earnings per share, diluted, SEK 3.34 3.55 14.48 13.22 Earnings per share, adjusted, diluted, SEK* 3.34 3.55 14.36 13.22 * For full detail, please refer to notes in the full year 2015 report. 33

Balance sheet in summary MSEK December 31, 2015 December 31, 2014 Intangible assets 1,048 1,030 Property, plant and equipment 2,240 2,074 Investments in associated companies and joint ventures 4,845 5,233 Other non-current financial receivables* 1,739 1,669 Current operating assets 3,220 4,255 Cash and cash equivalents 1,732 2,312 Total assets 14,824 16,573 Equity attributable to equity holders of the Parent 251 277 Non-controlling interests 1 1 Total equity 252 279 Non-current provisions 1,223 1,081 Non-current loans 7,613 7,803 Other non-current financial liabilities* 1,882 2,063 Current provisions 147 98 Current loans 653 1,141 Other current liabilities 3,054 4,109 Total equity and liabilities 14,824 16,573 * For full detail, please refer to notes in the full year 2015 report. 34

Cash flow in summary MSEK Jan-Dec 2015 Jan-Dec 2014 Cash flow from operating activities before changes in working capital* 3,730 2,893 Cash flow from changes in working capital 38 384 Net cash from operating activities 3,768 3,276 Purchase of property, plant and equipment -491-223 Proceeds from sale of property, plant and equipment 17 2 Purchase of intangible assets -14-5 Acquisition of subsidiaries -0-2 Investments in associated companies and joint ventures** -25-45 Changes in financial receivables etc. 0 0 Net cash used in investing activities -513-274 Changes in loans -637-1,802 Dividend paid to equity holders of the Parent -1,464-1,453 Repurchase of own shares -1,995-890 Stock options exercised 141 53 Other 31 4 Net cash used in financing activities -3,924-4,088 Net decrease in cash and cash equivalents -669-1,085 Cash and cash equivalents at the beginning of the period 2,312 3,164 Effect of exchange rate fluctuations on cash and cash equivalents 90 232 Cash and cash equivalents at the end of the period 1,732 2,312 * Includes an extra dividend of 555 MSEK from STG on September 30, 2015. ** For full detail, please refer to notes in the full year 2015 report. 35

Key ratios MSEK Full year 2015 Full year 2014 Operating margin, % 28.0 28.4 Operating capital, MSEK 8,030 8,314 Return on operating capital, % 49.6 47.1 EBITDA, MSEK* 4,368 4,083 EBITA, MSEK* 4,094 3,821 Net debt, MSEK 7,922 8,126 Investments in property, plant and equipment, MSEK* 491 223 EBITA interest cover 8.9 7.6 Excluding share of net profit in STG EBITA, MSEK* 3,734 3,487 Net debt/ebita* 2.1 2.3 Share data Shares outstanding, end of period (Mio) 188.9 195.7 Average number of shares outstanding, basic (Mio) 193.5 198.5 * For full detail, please refer to notes in the full year 2015 report. 36

Largest shareholders* As per December 31, 2015 Largest shareholders Standard Life Investment Funds 3.8% SEB Funds 2.9% Nordea Funds 2.3% Second Swedish National Pension Fund 2.2% First Swedish National Pension Fund 1.8% Invesco Funds 1.7% UBS Funds 1.1% SHB Funds 1.1% Vanguard Funds 0.9% Fourth Swedish National Pension Fund 0.9% 18.7% 49,805 shareholders Outside Sweden 74% Sweden 26% Source: Modular Finance AB, data derived from Euroclear Sweden AB. * Percent split of share capital held, excluding Swedish Match shares held in treasury. 37

Comparable sales Excluding businesses transferred to STG (MSEK) CAGR 10-15 Other operations Lights Other tobacco products Snus and moist snuff 11,222 2,831 1,429 2,440 * 11,666 3,206 1,346 2,388 * 12,486 3,437 1,339 2,661 5% 12,610 3,847 1,332 2,564 13,305 4,178 1,295 2,832 14,486 4,272 1,295 3,829 9% -2% 9% 4% 4,522 4,726 5,049 4,868 5,001 5,090 2% 2010 2011 2012 2013 2014 2015 38

Comparable operating profit Excluding businesses transferred to STG (MSEK) CAGR 10-15 3,158 279 942 3,365 240 1,049 3,666 222 1,161 +3% 3,375 230 1,029 3,446 218 1,109 3,690 190 1,554 Lights Other tobacco products Snus and moist snuff Other operations -7% 11% 3% * * 2,080 2,181 2,349 2,195 2,207 2,071 0% -142-105 -65-80 -88-125 2010 2011 2012 2013 2014 2015 39

Competing with cigarettes is not new to Swedish Match Volume development for cigarettes and snus in Sweden since 1916 Cigarettes (million packs) 700 630 560 490 420 350 Cigarettes Snus (million cans) 250 225 200 175 150 125 280 210 140 70 Snus 1973: First portion snus launched 100 75 50 25 0 0 1916 1925 1934 1943 1952 1961 1970 1979 1988 1997 2006 2015 Source: Swedish Match estimates. 40